Bioreactor Market size is set to exceed USD 1.9 billion by 2024; according to a new research report. Rising chronic disease prevalence and growing research in the field of biopharmaceuticals will drive the global bioreactor market size. Increased focus of biopharmaceutical companies to develop effective treatment options for orphan diseases should fuel industry growth.
- Agency -.
MaketStudyReport.com adds a New Bioreactor Market Research Report for the period of 2017-2024 that shows the growth of the market is rising at a 18% CAGR to 2024.
Increase in adoption of single-use technologies, use of hybrid technologies: single-use and stainless steel, growing popularity of single-use bioreactor among biopharmaceutical companies and growing biologics to drive the growth of the global bioreactors market. In addition to this, government support to create an innovative bio-economy has triggered the research and development activities and increase in incidences of lifestyle diseases such as diabetes and cancer and presence of favorable government initiatives made North American regions as an attractive destination to invest in biologics.
This report mainly considers three types of bioreactor material Glass, stainless steel, and single-use bioreactors.
- Agency -.
They are also used in academic and research institutes. The single-use segment commanded around 41% of the global bioreactors market, in terms of volume, in 2015.
The large percentage of this segment is attributed to the widespread usage of single-use bioreactors across clinical and commercial production.
Personalized medicines are changing the way many diseases are identified, classified, and treated. The growing personalized medicine market that involves a focused population base will further drive the bioreactor market size.
A new manufacturing technology has evolved to provide more personalized drug products such as 3D bioprinting.
Get sample Copy of this report: www.marketstudyreport.com/request-…tm_source=WAT-PSR
Mammalian cells market revenue is estimated to exceed USD 1.5 billion by 2024. It is widely used owing to its preference to product complex therapeutic proteins and enhanced compatibility for posttranslational modifications.
Monoclonal antibodies held more than 35% of the bioreactor market share in 2016, owing to increasing use in medical therapeutics attributed to its long half-life, high specificity, predictable pharmacokinetics, low toxicity, and high dose demand. The mAb therapeutics segment should flourish over the forecast years due to promising industry pipeline.
Single use bubble column bioreactor market size should witness over 18% CAGR over the forecast years. It is extensively used for cell line development, process development, and clinical trial manufacturing wherein they enhance the overall speed and effectiveness of media and cell line development.
U.S. bioreactor market size was valued at over USD 170 million in 2016 and is anticipated to witness significant growth over the coming years due to biopharmaceutical industry participants? focus on new drug development processes and growing number of strategic collaboration with academic institutions as well as venture capital firms.
Get this Report: www.marketstudyreport.com/check-for-discount/448834/
UK bioreactor market will witness over 17% CAGR, due to high healthcare spending and presence of large number of industry participants in this region. Increasing government initiatives to promote economic growth and improved quality of life should also drive industry growth.
Bioreactor market participants are Eppendorf, GE Healthcare, Merck Millipore, Sartorius, Thermo Fisher Scientific,. Industry participants engage in strategic collaborations, mergers & acquisitions coupled with new product launches in order to achieve competitive edge.
Bioreactor market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2013 to 2024, for the following segments:
Bioreactor Market, By Cell:
Mammalian cells, Bacterial cells, Yeast cells, Other cells
Bioreactor Market, By Molecule:
mAbs, Vaccine, Recombinant protein, Stem cell, Gene therapy, Other molecules
Bioreactor Market, By Technology:
Wave-induced motion SUB, Stirred SUB, Stirred use bubble column, Other
Bioreactor Market, By End Use:
Research and development (R&D), Biopharma manufacturers, Contract manufacturing organisations (CMOs)
The above information is provided on a regional and country basis for the following:
North America, U.S., Europe, UK, Russia, Asia Pacific, China, Australia, Indonesia, Malaysia, India, Pakistan, Middle East, UAE, Turkey, Africa, Cameroon, Congo, Egypt, Equatorial Guinea, Mozambique, Ghana, Latin America, Brazil, Chile, Colombia
Category: Market Research Publishers and RetailersCompany profile: Centralize market research purchases across your entire organization in one place.Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
For more information: